跳至主要内容
临床试验/NCT06012968
NCT06012968招募中不适用

Study on the Protective Effect of Gastrodin on Myocardial Injury in Patients Undergoing Cardiac Surgery

Wuhan Union Hospital, China1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2023年8月最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
10
试验地点
1
主要终点
Degree of myocardial cell injury

研究概览

简要总结

This study intends to include hypertrophic cardiomyopathy patients over 18 years old who underwent cardiac surgery in our hospital. Patients were divided into medication group and control group according to the use of gastrodin during operation. The patients ' myocardial tissue samples were collected, the postoperative prognosis data were observed and recorded, and the data were analyzed. The degree of myocardial tissue cell damage and postoperative clinical outcomes were compared between the two groups.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with hypertrophic cardiomyopathy aged≥18 years, regardless of gender;
  • Patients undergoing elective hypertrophic cardiomyopathy outflow tract surgery;
  • Signed informed consent, good compliance.

排除标准

  • suffering from more serious genetic diseases (such as immunodeficiency, thalassemia, etc.);
  • moderate to severe malnutrition, moderate to severe anemia;
  • persistent infection;
  • severe preoperative underlying diseases (such as severe liver and kidney dysfunction)

结局指标

主要结局

Degree of myocardial cell injury

时间窗: During postoperative hospitalization stay, an average of about two weeks

Postoperative myocardial injury marker serum concentration, postoperative cardiac function ultrasound index

次要结局

未报告次要终点

研究者

发起方
Wuhan Union Hospital, China
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验